Search

Search Constraints

You searched for: Author/Creator Testori, A.

Search Results

11. Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab. Issue 14 (September 2015)

12. Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab. Issue 14 (September 2015)

13. PO-0952: Hypofractionated WBI in large-breasted patients: long-term toxicity of a prospective series. (November 2020)

14. Pregnancy and melanoma: a European‐wide survey to assess current management and a critical literature overview. (27th May 2016)

15. Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy. (18th March 2016)

16. Risk stratification of sentinel node positive melanoma patients defines surgical management and adjuvant therapy treatment considerations. Issue 2 (February 2019)

17. Skin toxicity and cosmetic outcomes in early stage breast cancer patients treated with hypofractionation and simultaneous integrated boost using VMAT: results in 1, 000 patients. (March 2017)

18. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 1 (January 2018)

19. The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients – An EORTC Melanoma Group study. Issue 12 (December 2016)

20. Timing of completion lymphadenectomy after positive sentinel node biopsy in patients with melanoma. Issue 6 (20th February 2017)